{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:48:10Z","timestamp":1792176490971,"version":"4.4.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010886","name":"Nestle HealthCare Nutrition Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.obpill.2025.100205","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:25:59Z","timestamp":1756437959000},"page":"100205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-5994","authenticated-orcid":false,"given":"Angela","family":"Fitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5025-5448","authenticated-orcid":false,"given":"Linda","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-1408","authenticated-orcid":false,"given":"Harold Edward","family":"Bays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2025.100205_bib1","unstructured":"World Health Organization. Obesity and overweight. Fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"10.1016\/j.obpill.2025.100205_bib2","doi-asserted-by":"crossref","unstructured":"Emmerich S, Fryar C, Stierman B, Ogden C. Obesity and severe obesity prevalence in adults: united States, August 2021\u2013August 2023. NCHS Data Brief, no 508. https:\/\/dx.doi.org\/10.15620\/cdc\/159281.","DOI":"10.15620\/cdc\/159281"},{"key":"10.1016\/j.obpill.2025.100205_bib3","article-title":"Review on the update in obesity management: epidemiology","volume":"2","author":"Peri","year":"2024","journal-title":"BMJ Public Health"},{"key":"10.1016\/j.obpill.2025.100205_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.obpill.2025.100205_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.obpill.2025.100205_bib6","article-title":"Nonalcoholic fatty liver disease and obesity: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022","volume":"3","author":"Karjoo","year":"2022","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib7","article-title":"Cancer and obesity: an Obesity Medicine Association (OMA) Clinical practice statement (CPS) 2022","volume":"3","author":"Lazarus","year":"2022","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib8","article-title":"Obesity, diabetes mellitus, and cardiometabolic risk: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023","volume":"5","author":"Bays","year":"2023","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib9","article-title":"Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: an obesity medicine association (OMA) clinical practice statement (CPS) 2023","volume":"8","author":"Bindlish","year":"2023","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib10","article-title":"Obesity and hypertension: obesity medicine association (OMA) clinical practice statement (CPS) 2023","volume":"8","author":"Clayton","year":"2023","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.obpill.2025.100205_bib12","article-title":"Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the obesity medicine association and the national lipid Association 2024","volume":"10","author":"Bays","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102848","article-title":"Burden of disease attributable to high body mass index: an analysis of data from the global burden of disease study 2021","volume":"76","author":"Zhou","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2025.100205_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11739-024-03765-7","article-title":"Venous thrombosis and obesity: from clinical needs to therapeutic challenges","volume":"20","author":"La Rosa","year":"2025","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.obpill.2025.100205_bib16","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: an obesity Medicine Association (OMA) and expert joint perspective 2025","volume":"14","author":"Panganiban","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-014632","article-title":"Productivity loss due to overweight and obesity: a systematic review of indirect costs","volume":"7","author":"Goettler","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.obpill.2025.100205_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247307","article-title":"Association of body mass index with health care expenditures in the United States by age and sex","volume":"16","author":"Ward","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.obpill.2025.100205_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41387-024-00352-9","article-title":"Assessing the economic impact of obesity and overweight on employers: identifying opportunities to improve work force health and well-being","volume":"14","author":"Dall","year":"2024","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.obpill.2025.100205_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.obpill.2025.100205_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2025.100205_bib22","article-title":"Recent achievements and future directions of anti-obesity medications","volume":"47","author":"Grandl","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.obpill.2025.100205_bib23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jama.2024.10816","article-title":"Medications for obesity: a review","volume":"332","author":"Gudzune","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100205_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ajcnut.2023.04.017","article-title":"The weight-loss effect of GLP-1RAs glucagon-like peptide-1 receptor agonists in non-diabetic individuals with overweight or obesity: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials","volume":"118","author":"Liu","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.obpill.2025.100205_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/oby.24331","article-title":"Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status","author":"Gasoyan","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100205_bib26","series-title":"StatPearls","article-title":"Counseling patients with obesity","author":"Sheer","year":"2025"},{"key":"10.1016\/j.obpill.2025.100205_bib27","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society","volume":"15","author":"Mozaffarian","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2024.100472","article-title":"Obesity medications: a narrative review of current and emerging agents","volume":"6","author":"Qi","year":"2024","journal-title":"Osteoarthr Cartil Open"},{"key":"10.1016\/j.obpill.2025.100205_bib29","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100205_bib30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100205_bib35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/DMSO.S387116","article-title":"The efficacy of GLP-1 analogues on appetite parameters, gastric emptying, food preference and taste among adults with obesity: systematic review of randomized controlled trials","volume":"16","author":"Aldawsari","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.obpill.2025.100205_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100205_bib37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","article-title":"What is the pipeline for future medications for obesity?","volume":"49","author":"Melson","year":"2025","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.obpill.2025.100205_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/ANNALS-24-01590","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes : a systematic review of randomized controlled trials","volume":"178","author":"Moiz","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.obpill.2025.100205_bib39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100205_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100205_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100205_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100205_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14656566.2024.2436595","article-title":"Tirzepatide for overweight and obesity management","volume":"26","author":"Hamza","year":"2025","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.obpill.2025.100205_bib44","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100205_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2025.100205_bib46","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1210\/jendso\/bvab048.030","article-title":"Impact of semaglutide on body composition in adults with overweight or obesity: exploratory analysis of the STEP 1 study","volume":"5","author":"Wilding","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.obpill.2025.100205_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/obesities5020029","article-title":"Symptomatic adverse events and quality of life related to incretin-based medicines for obesity: a systematic review involving >400,000 subjects","volume":"5","author":"Kushner","year":"2025","journal-title":"Obesities"},{"key":"10.1016\/j.obpill.2025.100205_bib48","article-title":"Dietary intake by patients taking GLP-1 and dual GIP\/GLP-1 receptor agonists: a narrative review and discussion of research needs","volume":"11","author":"Christensen","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13841","article-title":"Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity","volume":"26","author":"Mechanick","year":"2025","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100205_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13370","article-title":"The magnitude and progress of lean body mass, fat-free mass, and skeletal muscle mass loss following bariatric surgery: a systematic review and meta-analysis","volume":"23","author":"Nuijten","year":"2022","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100205_bib51","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3390\/nu13072473","article-title":"Weight loss strategies and the risk of skeletal muscle mass loss","volume":"13","author":"McCarthy","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100205_bib52","article-title":"Obesity history, physical exam, laboratory, body composition, and energy expenditure: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022","volume":"1","author":"Burridge","year":"2022","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib53","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3390\/nu10121876","article-title":"Body composition changes in weight loss: strategies and supplementation for maintaining lean body mass, a brief review","volume":"10","author":"Willoughby","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100205_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland","year":"2024","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2025.100205_bib55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10522-015-9626-4","article-title":"The impact of obesity on skeletal muscle strength and structure through adolescence to old age","volume":"17","author":"Tomlinson","year":"2016","journal-title":"Biogerontology"},{"key":"10.1016\/j.obpill.2025.100205_bib56","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.clnu.2021.11.014","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"41","author":"Donini","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.obpill.2025.100205_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101617","article-title":"Sarcopenia definition: does it really matter? Implications for resistance training","volume":"78","author":"Smith","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.obpill.2025.100205_bib58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13395-022-00309-5","article-title":"The prevalence of low muscle mass associated with obesity in the USA","volume":"12","author":"Murdock","year":"2022","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.obpill.2025.100205_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","article-title":"Sarcopenic obesity in older adults: a clinical overview","volume":"20","author":"Prado","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.obpill.2025.100205_bib60","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3604","article-title":"Sarcopenia and sarcopenic obesity and mortality among older people","volume":"7","author":"Benz","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2025.100205_bib61","doi-asserted-by":"crossref","first-page":"379","DOI":"10.14336\/AD.2021.1006","article-title":"Sarcopenic obesity: an emerging public health problem","volume":"13","author":"Ji","year":"2022","journal-title":"Aging Dis"},{"key":"10.1016\/j.obpill.2025.100205_bib62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/oby.24172","article-title":"GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials","volume":"33","author":"Beavers","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100205_bib63","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/oby.24067","article-title":"Nutritional considerations with antiobesity medications","volume":"32","author":"Almandoz","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100205_bib64","article-title":"Obesity and malnutrition in children and adults: a clinical review","volume":"8","author":"Bradley","year":"2023","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000519503","article-title":"Malnutrition in obesity: is it possible?","volume":"15","author":"Kobyli\u0144ska","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2025.100205_bib66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12939-020-01330-0","article-title":"Urban poverty and nutrition challenges associated with accessibility to a healthy diet: a global systematic literature review","volume":"20","author":"Vilar-Compte","year":"2021","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.obpill.2025.100205_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodqual.2025.105507","article-title":"Characteristics and food consumption for current, previous, and potential consumers of GLP-1 s","volume":"129","author":"Dilley","year":"2025","journal-title":"Food Qual Prefer"},{"key":"10.1016\/j.obpill.2025.100205_bib68","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41366-024-01500-y","article-title":"Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities","volume":"49","author":"Bettadapura","year":"2025","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.obpill.2025.100205_bib69","article-title":"Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: a retrospective observational study","volume":"15","author":"Scott Butsch","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib70","doi-asserted-by":"crossref","first-page":"R1755","DOI":"10.1152\/ajpregu.00472.2011","article-title":"Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake","volume":"301","author":"McKay","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.obpill.2025.100205_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151800","article-title":"A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia","volume":"131","author":"Winzeler","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.obpill.2025.100205_bib73","first-page":"SP226","article-title":"Chapter 2. Clinical nutrition guideline for overweight and obese adults with type 2 diabetes (T2D) or prediabetes, or those at high risk for developing T2D","volume":"24","author":"Hamdy","year":"2018"},{"key":"10.1016\/j.obpill.2025.100205_bib74","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.numecd.2024.08.001","article-title":"A systematic review of physical activity and nutritional interventions for the management of normal weight and overweight obesity","volume":"34","author":"Jacob","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.obpill.2025.100205_bib75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s13668-024-00548-6","article-title":"Nutritional considerations during major weight loss therapy: focus on optimal protein and a low-carbohydrate dietary pattern","volume":"13","author":"Volek","year":"2024","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/j.obpill.2025.100205_bib76","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7570\/jomes20028","article-title":"Clinical evidence and mechanisms of high-protein diet-induced weight loss","volume":"29","author":"Moon","year":"2020","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.obpill.2025.100205_bib77","doi-asserted-by":"crossref","first-page":"1558S","DOI":"10.1093\/ajcn\/87.5.1558S","article-title":"Protein, weight management, and satiety","volume":"87","author":"Paddon-Jones","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.obpill.2025.100205_bib78","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/oby.23930","article-title":"Physical activity in the new era of antiobesity medications","volume":"32","author":"Jakicic","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100205_bib79","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/nutrit\/nuad007","article-title":"Nutritional and exercise interventions in individuals with sarcopenic obesity around retirement age: a systematic review and meta-analysis","volume":"81","author":"Eglseer","year":"2023","journal-title":"Nutr Rev"},{"key":"10.1016\/j.obpill.2025.100205_bib80","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jphys.2020.09.009","article-title":"Resistance training leads to large improvements in strength and moderate improvements in physical function in adults who are overweight or obese: a systematic review","volume":"66","author":"Orange","year":"2020","journal-title":"J Physiother"},{"key":"10.1016\/j.obpill.2025.100205_bib81","article-title":"Nutrition and physical activity: an Obesity Medicine Association (OMA) Clinical Practice Statement 2022","volume":"1","author":"Alexander","year":"2022","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib82","article-title":"Contemporary treatments for obesity: physical activity in the context of antiobesity medications","volume":"9","author":"Jakicic","year":"2024","journal-title":"Transl J Am Coll Sports Med"},{"key":"10.1016\/j.obpill.2025.100205_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13273","article-title":"Exercise training in the management of overweight and obesity in adults: synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group","volume":"22","author":"Oppert","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100205_bib84","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.obpill.2025.100205_bib85","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/s40279-022-01704-0","article-title":"Effects of protein supplementation associated with resistance training on body composition and muscle strength in older adults: a systematic review of systematic reviews with meta-analyses","volume":"52","author":"Vieira","year":"2022","journal-title":"Sports Med"},{"key":"10.1016\/j.obpill.2025.100205_bib86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/nutrit\/nuaa064","article-title":"Factors influencing the efficacy of nutritional interventions on muscle mass in older adults: a systematic review and meta-analysis","volume":"79","author":"Martin-Cantero","year":"2021","journal-title":"Nutr Rev"},{"key":"10.1016\/j.obpill.2025.100205_bib87","article-title":"Why are we still in need for novel anti-obesity medications?","volume":"47","author":"Novikoff","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.obpill.2025.100205_bib88","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/gerona\/glad033","article-title":"Challenges and future prospects of targeting myostatin\/activin a signaling to treat diseases of muscle loss and metabolic dysfunction","volume":"78","author":"Lee","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.obpill.2025.100205_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.15135","article-title":"Selective androgen receptor modulators (sarms) effects on physical performance: a systematic review of randomized control trials","volume":"102","author":"Wen","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.obpill.2025.100205_bib90","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-025-09967-4","article-title":"New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?","author":"Ryan","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.obpill.2025.100205_bib91","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3945\/an.116.014506","article-title":"Preserving healthy muscle during weight loss","volume":"8","author":"Cava","year":"2017","journal-title":"Adv Nutr"},{"key":"10.1016\/j.obpill.2025.100205_bib92","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11695-020-05082-2","article-title":"Measuring muscle mass and strength in obesity: a review of various methods","volume":"31","author":"Sizoo","year":"2021","journal-title":"Obes Surg"},{"key":"10.1016\/j.obpill.2025.100205_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2024.112601","article-title":"The evolution of bioimpedance analysis: from traditional methods to wearable technology","volume":"129","author":"Mehra","year":"2025","journal-title":"Nutrition"},{"key":"10.1016\/j.obpill.2025.100205_bib94","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1017\/S1368980022002518","article-title":"How might enhanced interprofessional collaboration between primary care physicians and registered dietitian nutritionists impact clinical outcomes related to obesity and associated illnesses? A commentary","volume":"26","author":"Qubty","year":"2023","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.obpill.2025.100205_bib95","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1001\/jama.2019.17297","article-title":"Medical students around the world poorly trained in nutrition","volume":"322","author":"Abbasi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100205_bib96","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12875-022-01811-x","article-title":"Primary care physicians' knowledge and attitudes about obesity, adherence to treatment guidelines and association with confidence to treat obesity: a Swedish survey study","volume":"23","author":"Carrasco","year":"2022","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.obpill.2025.100205_bib98","author":"Brown"},{"key":"10.1016\/j.obpill.2025.100205_bib99","article-title":"Optimizing nutrition, diet, and lifestyle communication in GLP-1 medication therapy for weight management: a qualitative research study with registered dietitians","volume":"12","author":"Despain","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib100","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jand.2023.11.013","article-title":"Position of the Academy of Nutrition and Dietetics: medical nutrition therapy behavioral interventions provided by dietitians for adults with overweight or obesity, 2024","volume":"124","author":"Raynor","year":"2024","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.obpill.2025.100205_bib101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jand.2024.10.023","article-title":"Incretin-based therapies and lifestyle interventions: the evolving role of registered dietitian nutritionists in obesity care","volume":"125","author":"Gigliotti","year":"2025","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.obpill.2025.100205_bib102","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000528083","article-title":"European Association for the Study of Obesity position statement on medical nutrition therapy for the management of overweight and obesity in adults developed in collaboration with the European Federation of the Associations of Dietitians","volume":"16","author":"Hassapidou","year":"2023","journal-title":"Obes Facts"},{"key":"10.1016\/j.obpill.2025.100205_bib103","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jand.2022.03.014","article-title":"Weight management interventions provided by a dietitian for adults with overweight or obesity: an evidence analysis center systematic review and meta-analysis","volume":"123","author":"Morgan-Bathke","year":"2023","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/j.obpill.2025.100205_bib104","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ajcnut.2023.08.022","article-title":"The effectiveness of medical nutrition therapy provided by a dietitian in adults with prediabetes: a systematic review and meta-analysis","volume":"118","author":"Dudzik","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.obpill.2025.100205_bib105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.122.009348","article-title":"Long-term effect of weight regain following behavioral weight management programs on cardiometabolic disease incidence and risk: systematic review and meta-analysis","volume":"16","author":"Hartmann-Boyce","year":"2023","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.obpill.2025.100205_bib106","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacl.2022.06.008","article-title":"Effectiveness of medical nutrition therapy in the management of adult dyslipidemia: a systematic review and meta-analysis","volume":"16","author":"Mohr","year":"2022","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.obpill.2025.100205_bib107","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.3390\/nu15214610","article-title":"Dietary assessment for weight management and health maintenance","volume":"15","author":"Reche-Garc\u00eda","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.obpill.2025.100205_bib108","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13679-023-00534-z","article-title":"The role of lifestyle modification with second-generation anti-obesity medications: comparisons, questions, and clinical opportunities","volume":"12","author":"Wadden","year":"2023","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.obpill.2025.100205_bib109","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.obpill.2025.100205_bib110","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/dc07-0048","article-title":"Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial","volume":"30","author":"Look AHEAD Research Group","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100205_bib111","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/dom.15819","article-title":"The latest evidence and clinical guidelines for use of meal replacements in very-low-calorie diets or low-calorie diets for the treatment of obesity","volume":"26","author":"Edwards-Hampton","year":"2024","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2025.100205_bib112","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2337\/dci19-0014","article-title":"Nutrition therapy for adults with diabetes or prediabetes: a consensus report","volume":"42","author":"Evert","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2025.100205_bib113","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2023-000246","article-title":"Review on obesity management: diet, exercise and pharmacotherapy","volume":"2","author":"Peri","year":"2024","journal-title":"BMJ Public Health"},{"key":"10.1016\/j.obpill.2025.100205_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102475","article-title":"Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial","volume":"69","author":"Jensen","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.obpill.2025.100205_bib115","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","article-title":"World Health Organization 2020 guidelines on physical activity and sedentary behaviour","volume":"54","author":"Bull","year":"2020","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.obpill.2025.100205_bib116","unstructured":"US Department of Health and Human Services. Physical activity \u223cguidelines for Americans. second ed. https:\/\/odphp.health.gov\/sites\/default\/files\/2019-09\/PAG_Advisory_Committee_Report.pdf."},{"key":"10.1016\/j.obpill.2025.100205_bib117","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S000711452200160X","article-title":"The emerging importance of tackling sleep-diet interactions in lifestyle interventions for weight management","volume":"128","author":"Hall","year":"2022","journal-title":"Br J Nutr"},{"key":"10.1016\/j.obpill.2025.100205_bib118","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity","volume":"26","author":"Rubino","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.obpill.2025.100205_bib119","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12615","article-title":"Moving beyond eat less, move more using willpower: reframing obesity as a chronic disease impact of the 2020 Canadian obesity guidelines reframed narrative on perceptions of self and the patient-provider relationship","volume":"13","author":"English","year":"2023","journal-title":"Clin Obes"},{"key":"10.1016\/j.obpill.2025.100205_bib120","article-title":"Obesity pillars roundtable: excessive weight reduction with highly effective anti-obesity medications (heAOMs)","volume":"4","author":"Bays","year":"2022","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib121","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.33326","article-title":"One-year weight reduction with semaglutide or liraglutide in clinical practice","volume":"7","author":"Gasoyan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2025.100205_bib122","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13885","article-title":"Determinants of adherence to obesity medication: a narrative review","volume":"26","author":"Sharma","year":"2025","journal-title":"Obes Rev"},{"key":"10.1016\/j.obpill.2025.100205_bib123","first-page":"860","article-title":"Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes","volume":"30","author":"Gleason","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.obpill.2025.100205_bib125","first-page":"24","article-title":"The new weight management meds","volume":"25","author":"Warshaw","year":"2023","journal-title":"Todays Dietitian"},{"key":"10.1016\/j.obpill.2025.100205_bib126","author":"Moorman"},{"key":"10.1016\/j.obpill.2025.100205_bib127","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.13172","article-title":"GLP-1 Receptor agonist discontinuation among patients with obesity and\/or type 2 diabetes","volume":"7","author":"Do","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2025.100205_bib128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/jcm12010145","article-title":"Clinical recommendations to manage gastrointestinal adverse events in patients treated with Glp-1 receptor agonists: a multidisciplinary expert consensus","volume":"12","author":"Gorgojo-Martinez","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.obpill.2025.100205_bib129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00325481.2021.2002616","article-title":"Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice","volume":"134","author":"Wharton","year":"2022","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.obpill.2025.100205_bib130","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2025.100205_bib131","article-title":"GLP-1 receptor agonists: a magic bullet for obesity?","volume":"51","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.obpill.2025.100205_bib132","article-title":"Navigating coverage: a qualitative study exploring the perceived impact of an insurance company policy to discontinue coverage of antiobesity medication","volume":"11","author":"Haggerty","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib133","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.obpill.2025.100205_bib134","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25505","article-title":"Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016","volume":"3","author":"Yao","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2025.100205_bib135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11883-012-0291-7","article-title":"How do we improve patient compliance and adherence to long-term statin therapy?","volume":"15","author":"Maningat","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.obpill.2025.100205_bib136","first-page":"27","article-title":"Polypharmacy and medication adherence: how to do better for our patients","volume":"31","author":"Larson","year":"2024","journal-title":"Fam Pract Manag"},{"key":"10.1016\/j.obpill.2025.100205_bib137","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/oby.22054","article-title":"Perceptions of barriers to effective obesity care: results from the National ACTION Study","volume":"26","author":"Kaplan","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.obpill.2025.100205_bib138","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12329","article-title":"Perceptions of barriers to effective obesity management in Canada: results from the ACTION study","volume":"9","author":"Sharma","year":"2019","journal-title":"Clin Obes"},{"key":"10.1016\/j.obpill.2025.100205_bib139","article-title":"Bariatric nutrition and evaluation of the metabolic surgical patient: update to the 2022 Obesity Medicine Association (OMA) bariatric surgery, gastrointestinal hormones, and the microbiome clinical practice statement (CPS)","volume":"13","author":"Benson-Davies","year":"2024","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2025.100205_bib140","first-page":"1346","volume":"25","author":"Mechanick","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.obpill.2025.100205_bib141","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/oby.23154","article-title":"Weight can't wait: a guide to discussing obesity and organizing treatment in the primary care setting","volume":"29","author":"Gallagher","year":"2021","journal-title":"Obesity (Silver Spring)"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266736812500049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266736812500049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:59:52Z","timestamp":1772920792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266736812500049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":133,"alternative-id":["S266736812500049X"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2025.100205","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2025.100205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100205"}}